Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Nucleic Acids Research
|
May 17, 2021
m6A RNA methylation of major satellite repeat transcripts facilitates chromatin association and RNA:DNA hybrid formation in mouse heterochromatin
Katarzyna J Duda, Reagan W Ching, Lisa Jerabek, et al.
The British Journal of Dermatology
|
August 25, 2010
CHIA confers susceptibility to childhood eczema
T F Leung, K W Ching, H Y Sy, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
March 27, 2010
Serum levels of heavy metals in childhood eczema and skin diseases: friends or foes
Kam-Lun E Hon, Shuxin Susan Wang, Emily C W Hung, et al.
Journal of Medicinal Chemistry
|
April 25, 2020
Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists
Joseph R Fotsing, Vincent Darmohusodo, Andrew P Patron, et al.
Frontiers in Psychiatry
|
May 14, 2023
Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial
Terence H W Ching, Rachael Grazioplene, Calvin Bohner, et al.
Nature Genetics
|
February 6, 2007
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome
Nathaniel D Heintzman, Rhona K Stuart, Gary Hon, et al.
Frontiers in Psychiatry
|
January 24, 2024
Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings
Terence H W Ching, Lucia Amoroso, Calvin Bohner, et al.
Frontiers in Psychiatry
|
March 4, 2024
Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings
Terence H W Ching, Lucia Amoroso, Calvin Bohner, et al.
Nature
|
March 4, 2011
Copy number variation and selection during reprogramming to pluripotency
Samer M Hussein, Nizar N Batada, Sanna Vuoristo, et al.
Nature
|
March 20, 2009
Histone modifications at human enhancers reflect global cell-type-specific gene expression
Nathaniel D Heintzman, Gary C Hon, R David Hawkins, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Nucleic Acids Research
|
May 17, 2021
m6A RNA methylation of major satellite repeat transcripts facilitates chromatin association and RNA:DNA hybrid formation in mouse heterochromatin
Katarzyna J Duda, Reagan W Ching, Lisa Jerabek, et al.
The British Journal of Dermatology
|
August 25, 2010
CHIA confers susceptibility to childhood eczema
T F Leung, K W Ching, H Y Sy, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
March 27, 2010
Serum levels of heavy metals in childhood eczema and skin diseases: friends or foes
Kam-Lun E Hon, Shuxin Susan Wang, Emily C W Hung, et al.
Journal of Medicinal Chemistry
|
April 25, 2020
Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists
Joseph R Fotsing, Vincent Darmohusodo, Andrew P Patron, et al.
Frontiers in Psychiatry
|
May 14, 2023
Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial
Terence H W Ching, Rachael Grazioplene, Calvin Bohner, et al.
Nature Genetics
|
February 6, 2007
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome
Nathaniel D Heintzman, Rhona K Stuart, Gary Hon, et al.
Frontiers in Psychiatry
|
January 24, 2024
Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings
Terence H W Ching, Lucia Amoroso, Calvin Bohner, et al.
Frontiers in Psychiatry
|
March 4, 2024
Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings
Terence H W Ching, Lucia Amoroso, Calvin Bohner, et al.
Nature
|
March 4, 2011
Copy number variation and selection during reprogramming to pluripotency
Samer M Hussein, Nizar N Batada, Sanna Vuoristo, et al.
Nature
|
March 20, 2009
Histone modifications at human enhancers reflect global cell-type-specific gene expression
Nathaniel D Heintzman, Gary C Hon, R David Hawkins, et al.
Page
of 12